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1.1. Solid-phase synthesis of peptide thioureas and thiazole-containing
macrocycles
Thioureas occur in a number of biologically-active molecules,
with a range of pharmacological properties including analgesic,
anticancer, antifungal and antibacterial properties. In addition,
thiourea derivatives are potent inhibitors of enzymatic targets for
medical use. Thioureas can also be synthetically converted into thi-
azoles, a heterocycle that occurs both in nature and in many drug
molecules. A recent paper has presented a novel method for the
solid-phase synthesis of a-thiourea peptides, which were subse-
quently converted to thiazoles and incorporated into macrocyclic
structures through ring-closing oleﬁn metathesis [1].
The activation of N,N’-di-Boc-thiourea with CuSO4, HgCl2 or
Mukaiyama’s reagent is a well-known method for the generation
of guanidines. However, it was found that conditions could be
modiﬁed such that the major product of the reaction of the thio-
urea with a solid-supported amino acid was the thiourea peptide.
For example, phenylalanine immobilised on 4-hydroxymethyl-
benzoic acid (HMBA) resin (1) was treated with a pre-mixed solu-
tion in dry DMF of N,N’-di-Boc-thiourea (2), Mukaiyama’s reagent
(3) and triethylamine to give predominantly the thiourea deriva-
tive (4) rather than a guanidine derivative.
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E-mail address: nterrett@ensembletx.comWith conditions having been optimised for formation of
a-thiourea peptides, the approach was successfully tested on the
range of 20 proteinogenic amino acids, generating products in good
yield irrespective of the size and nature of the side-chains. Depro-
tection of the thiourea (removing the Boc group) proceeded cleanly
by treating with dilute stannic chloride in dichloromethane to give
5, and thiazole formation was achieved by the Hantzsch reaction
with a-haloketones to give 6.
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The scene was now set to attempt the formation of macrocy-
cles containing thiazoles. A small collection of thiazoles was pre-
pared using the protocol outlined above. In particular, cyclisation
to the thiazole using bromopyruvic acid generated carboxylated
thiazoles (7) which could undergo amide-forming reactions with
amines following on-resin activation. Having already incorporated
an allylglycine residue on the carboxy-terminal side of the pep-
tide, coupling with an alkene on the carboxylated thiazole to give
8, permitted macrocyclisation to product 9 by ring closing
metathesis (RCM). The RCM reaction was found to proceed most
successfully with the Hoveyda Grubbs second generation catalyst,
generating a range of macrocycles with from 15 to 17 atoms. It
was found that the reaction was sufﬁciently ﬂexible to prepare
any of four possible diastereoisomers, in excellent product yields
and purities.
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Overall, this newmethodology provides a mild and selective ap-
proach to N-terminally modiﬁed a-thiourea peptides on solid sup-
port. The approach has further been used to prepare a number of
thiazoles and thiazole-containing macrocycles by the RCM
reaction.
2. A summary of the papers in this month’s issue
2.1. Polymer supported synthesis
No papers this month.
2.2. Solution-phase synthesis
Multi-component reactions (MCRs) feature the potential for
abundant reagent combinations, inputs, and post-MCR modiﬁca-
tions, which result in exceptionally high diversiﬁcation power.
An expeditious cascade protocol for the synthesis of functionalised
imidazo[1,2-a]pyridin-3-ols has been developed based on the Peta-
sis reaction. With the availability of commercial reagents and high
efﬁciency in expanding molecule diversity, this method offers
advantages to the existing procedures for the synthesis of imi-
dazo-pyridin-3-ol analogues [2].
A previously unknown class of highly substituted benzoquino-
line–spirooxindoles has been easily prepared by a novel applica-
tion of a mild and efﬁcient catalyst, SbCl3, for carbon–carbon and
carbon–nitrogen bond formation reactions. The approach reacted
isatins and alkynes (dialkyl but-2-ynedioate) with an aromatic
amine (2-naphthylamine) in a one-pot three-component reaction
to give a library of dialkyl 20-oxo-4H-spiro[benzo[f]quinoline-3,30-
indoline]-1,2-dicarboxylate derivatives in very good to excellent
yields [3].
An efﬁcient synthesis of diverse 2-aryl/heteroaryl substituted
pyrimidinyl ethanones has been developed using a palladium-cat-
alyzed Suzuki–Miyaura coupling reaction strategy. Use of Pd(OAc)2
in the presence of PPh3 and Na2CO3 in 1,4-dioxane solvent was
found to be the most effective reaction condition for this transfor-
mation [4].The catalytic, highly regio-, diastereo-, and enantioselective
synthesis of a small library of chiral spirooxindolopyrrolizidines
has been described. This approach proceeds via a three-component
1,3-dipolar cycloaddition reaction of azomethine ylides, derived
from isatin, with electron-deﬁcient dipolarophiles, and 3-(2-alke-
noyl)-1,3-oxazolidin-2-ones. A chiral copper(II) complex of cyclo-
hexane-1,2-bis(arylmethyleneamine) catalysed this process at
room temperature [5].
A domino reaction for the rapid and diverse synthesis of spir-
o[1H-pyrazolo[3,4-b]benzo[h]dihydroquinolin-4,3-indolin-2-ones]
has been reported. The synthesis represents a thermodynamically-
favoured four-component reaction between phenylhydrazine, isa-
tins, naphthylamines, and 3-ketoesters giving novel products in
excellent yields under solvent-free conditions [6].
2.3. Scaffolds and synthons for combinatorial libraries
The efﬁcient synthesis of novel glycoconjugate amino acid
building blocks wherein the amino acid and carbohydrate moieties
are linked via a sulphonamide functional group has been reported.
The general reaction sequence consists of coupling a glycosyl thio-
acetate to an amino acid methyl ester followed by oxidation and
deprotection of the carbohydrate moiety. The synthesis of deriva-
tives from a range of amino acids has been demonstrated, with
reaction at either the a-amino group of amino acid precursors or
the sidechain e-amino group of lysine precursors [7].
2.4. Solid-phase supported reagents
In a recent paper, a variety of ketoximes, prepared from the
corresponding ketones, undergo Beckmann rearrangement using
H3PW12O40 (DTPA) in acetonitrile under reﬂux to yield
N-substituted amides and lactams in good to excellent yields
(72–96%). The method provides an efﬁcient, clean, eco-friendly,
and simple synthesis, using a catalyst which is cheap, moisture
tolerant, recoverable, and reusable without much loss of its
activity [8].
An efﬁcient one-pot synthesis of 2-substituted quinoxalines
from 1,2-diamines and phenacyl bromides has been developed
using K10-montmorillonite (K10 clay) as a catalyst at 50 C in ace-
tonitrile. The method offers an easy route for the synthesis of
substituted quinoxalines in high yields, and a plausible mechanism
has been proposed. Furthermore, the K10 clay catalyst can be
recovered by simple ﬁltration and reused six times without any
loss in its catalytic activity [9].
The development of sustainable catalysts that can combine
advantages from both homogeneous and heterogeneous catalysis
has raised considerable promise over the last decade. To this end,
using ligation chemistries that show high functional tolerance, that
are highly efﬁcient, speciﬁc, versatile, and that require mild condi-
tions are particularly favoured. Following these guidelines, the
copper-catalysed azide–alkyne cycloaddition reaction (CuAAC)
has been employed for the heterogenisation of homogeneous cata-
lysts [10].
2.5. Novel resins, linkers and techniques
No papers this month.
2.6. Library applications
A four-component Ugi reaction (Ugi-4CR) using formylphenyl
boronic acids under mild conditions has been developed for
the synthesis of arylboronic acid analogues. The reactions
were performed in methanol and accelerated by microwave
irradiation, which makes this strategy suitable for constructing
N.K. Terrett / Combinatorial Chemistry - An Online Journal 16 (2014) 13–15 15boronic-containing chemical libraries. Two of the synthesised
analogues were found to have cytotoxic activity against HepG2,
MDA-MB231, and A549 cancer cell lines, demonstrating the
potential application of this approach in developing novel boron-
containing pharmaceuticals [11].
With a broad spectrum of antiviral activity against clinically rel-
evant mutant viruses, analogues from a new pyridone series met a
mandatory criterion for next generation NNRTIs. Using a simple
synthetic approach, a library of inhibitors was constructed, leading
to the identiﬁcation of a new pyridone. In cell cultures, this new
NNRTI shows a superior potency proﬁle against a range of wild
type and clinically relevant, resistant mutant HIV viruses [12].
In an effort to improve a therapy for giardiasis and amoebic dys-
entery, the creation of chemical libraries is necessary to obtain no-
vel drugs with high activity combined with low toxicity. The
synthesis of novel 3-tetrazolylmethyl-4H-chromen-4-ones via an
Ugi-azide multicomponent reaction and their biological evaluation
against Entamoeba histolytica, Giardia lamblia and Trichomona vag-
inalis has been described. Biological results show that these com-
pounds could be considered as candidates to anti-parasitic drugs,
especially against G. lamblia [13].
Oroidin, (E)-N-(3-(2-amino-1H-imidazol-4-yl)allyl)-4,5-dibro-
mo-1H-pyrrole-2-carboxamide, is a pyrrole alkaloid isolated from
the marine sponge Agelas oroides. Routine screening in a panel of
twelve cancer cell lines revealed the compound to be only poorly
cytotoxic. The development of eight focused libraries comprising
thirty compounds in total revealed two new compounds as potent
inhibitors of cell growth in the panel of cell lines [14].
MurF ligase is a crucial enzyme that catalyses the ultimate
intracellular step of bacterial peptidoglycan biosynthesis, and thus
represents an attractive target for antibacterial drug discovery. The
design, synthesis and evaluation of a new series of cyanothioph-
ene-based inhibitors of MurF enzymes from Streptococcus pneumo-
niae and Escherichia coli have been described. Different structural
modiﬁcations of the parent compounds resulted in a focused li-
brary of 37 new inhibitors, providing low micromolar inhibitors
of MurF from E. coli and S. pneumoniae [15].References
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